 Kenneth Tyler
Concepts (771)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reoviridae Infections | 40 | 2019 | 55 | 8.580 |
Why?
| | West Nile Fever | 22 | 2023 | 51 | 7.690 |
Why?
| | Encephalitis, Viral | 23 | 2021 | 42 | 6.350 |
Why?
| | West Nile virus | 17 | 2023 | 38 | 6.280 |
Why?
| | Enterovirus D, Human | 13 | 2023 | 76 | 5.900 |
Why?
| | Enterovirus Infections | 13 | 2023 | 164 | 5.150 |
Why?
| | Central Nervous System Viral Diseases | 17 | 2023 | 63 | 5.060 |
Why?
| | Reoviridae | 26 | 2019 | 38 | 4.690 |
Why?
| | Myelitis | 20 | 2022 | 88 | 4.690 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 15 | 2019 | 39 | 4.450 |
Why?
| | Mammalian orthoreovirus 3 | 30 | 2019 | 35 | 4.050 |
Why?
| | Nervous System Diseases | 15 | 2020 | 261 | 3.810 |
Why?
| | Apoptosis | 44 | 2021 | 2461 | 3.720 |
Why?
| | Brain | 37 | 2023 | 2481 | 3.510 |
Why?
| | Antiviral Agents | 19 | 2023 | 653 | 3.150 |
Why?
| | Neuromuscular Diseases | 9 | 2022 | 90 | 2.390 |
Why?
| | Central Nervous System Infections | 7 | 2022 | 38 | 2.330 |
Why?
| | Neurology | 12 | 2017 | 94 | 2.280 |
Why?
| | Zika Virus Infection | 5 | 2017 | 85 | 2.240 |
Why?
| | Encephalitis | 8 | 2022 | 127 | 1.950 |
Why?
| | Acyclovir | 9 | 2020 | 105 | 1.920 |
Why?
| | Neurons | 21 | 2022 | 1340 | 1.910 |
Why?
| | Paralysis | 9 | 2023 | 67 | 1.880 |
Why?
| | Encephalitis, Herpes Simplex | 8 | 2020 | 23 | 1.830 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 299 | 1.770 |
Why?
| | Mice | 74 | 2023 | 15446 | 1.740 |
Why?
| | Animals | 107 | 2023 | 33152 | 1.680 |
Why?
| | Microglia | 7 | 2023 | 220 | 1.670 |
Why?
| | Multiple Sclerosis | 5 | 2022 | 384 | 1.530 |
Why?
| | Simplexvirus | 13 | 2020 | 86 | 1.510 |
Why?
| | Meningoencephalitis | 6 | 2021 | 24 | 1.510 |
Why?
| | Herpes Simplex | 7 | 2021 | 90 | 1.390 |
Why?
| | Zika Virus | 4 | 2017 | 61 | 1.390 |
Why?
| | Polymerase Chain Reaction | 17 | 2018 | 1004 | 1.370 |
Why?
| | Communicable Diseases, Emerging | 4 | 2016 | 28 | 1.330 |
Why?
| | Spinal Cord | 8 | 2021 | 367 | 1.320 |
Why?
| | Central Nervous System Diseases | 5 | 2023 | 64 | 1.300 |
Why?
| | Cell Death | 4 | 2022 | 336 | 1.280 |
Why?
| | Humans | 157 | 2023 | 118268 | 1.250 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 449 | 1.220 |
Why?
| | Herpesviridae Infections | 6 | 2013 | 140 | 1.220 |
Why?
| | Viral Load | 6 | 2023 | 406 | 1.200 |
Why?
| | Meningitis, Viral | 8 | 2020 | 22 | 1.170 |
Why?
| | Virus Replication | 19 | 2021 | 398 | 1.110 |
Why?
| | Central Nervous System | 9 | 2017 | 243 | 1.100 |
Why?
| | Interferon-beta | 4 | 2019 | 82 | 1.090 |
Why?
| | JC Virus | 8 | 2015 | 23 | 1.070 |
Why?
| | Disease Outbreaks | 6 | 2022 | 322 | 1.070 |
Why?
| | Disease Models, Animal | 13 | 2023 | 3676 | 1.050 |
Why?
| | Meningitis | 4 | 2023 | 74 | 1.050 |
Why?
| | Arbovirus Infections | 3 | 2019 | 18 | 1.040 |
Why?
| | Epstein-Barr Virus Infections | 2 | 2022 | 73 | 1.020 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 347 | 1.020 |
Why?
| | Coronavirus Infections | 2 | 2020 | 338 | 1.010 |
Why?
| | Motor Neurons | 3 | 2019 | 213 | 0.980 |
Why?
| | Monkeypox virus | 3 | 2023 | 12 | 0.980 |
Why?
| | Herpesvirus 1, Human | 3 | 2021 | 81 | 0.970 |
Why?
| | Cytokines | 9 | 2022 | 1880 | 0.960 |
Why?
| | Creutzfeldt-Jakob Syndrome | 5 | 2007 | 14 | 0.950 |
Why?
| | Orthoreovirus, Mammalian | 4 | 2011 | 5 | 0.940 |
Why?
| | Signal Transduction | 17 | 2019 | 4688 | 0.940 |
Why?
| | Virion | 3 | 2022 | 77 | 0.930 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 142 | 0.920 |
Why?
| | Caspase 3 | 7 | 2023 | 240 | 0.910 |
Why?
| | Guillain-Barre Syndrome | 3 | 2020 | 21 | 0.910 |
Why?
| | Dog Diseases | 2 | 2021 | 43 | 0.910 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 136 | 0.900 |
Why?
| | Capsid Proteins | 8 | 2004 | 70 | 0.880 |
Why?
| | Natalizumab | 4 | 2019 | 46 | 0.880 |
Why?
| | Minocycline | 2 | 2017 | 28 | 0.880 |
Why?
| | Astrocytes | 5 | 2019 | 176 | 0.840 |
Why?
| | Virus Diseases | 7 | 2009 | 197 | 0.840 |
Why?
| | Spine | 2 | 2017 | 144 | 0.830 |
Why?
| | Fluoxetine | 3 | 2018 | 47 | 0.830 |
Why?
| | Immunity, Innate | 5 | 2021 | 744 | 0.810 |
Why?
| | Meningitis, Bacterial | 4 | 2010 | 51 | 0.800 |
Why?
| | Caspase Inhibitors | 5 | 2011 | 79 | 0.780 |
Why?
| | Exosomes | 1 | 2022 | 92 | 0.770 |
Why?
| | Critical Care | 2 | 2017 | 488 | 0.750 |
Why?
| | Betacoronavirus | 2 | 2020 | 253 | 0.740 |
Why?
| | Encephalitis, Tick-Borne | 2 | 2019 | 8 | 0.730 |
Why?
| | Encephalitis, California | 2 | 2019 | 12 | 0.730 |
Why?
| | Hashimoto Disease | 1 | 2019 | 9 | 0.720 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2019 | 9 | 0.710 |
Why?
| | Axonal Transport | 1 | 2019 | 21 | 0.710 |
Why?
| | Immunosuppressive Agents | 3 | 2015 | 682 | 0.700 |
Why?
| | Zoonoses | 2 | 2009 | 20 | 0.700 |
Why?
| | Cell Line | 18 | 2022 | 2693 | 0.690 |
Why?
| | Periodicals as Topic | 1 | 2021 | 187 | 0.680 |
Why?
| | Immune System | 2 | 2020 | 181 | 0.680 |
Why?
| | Encephalitis, Japanese | 1 | 2018 | 2 | 0.670 |
Why?
| | Orthoreovirus | 5 | 1998 | 6 | 0.660 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 5 | 2009 | 155 | 0.640 |
Why?
| | Prion Diseases | 3 | 2008 | 11 | 0.610 |
Why?
| | Neurosyphilis | 2 | 2013 | 3 | 0.600 |
Why?
| | Hepatitis E | 1 | 2017 | 2 | 0.590 |
Why?
| | Hepatitis E virus | 1 | 2017 | 2 | 0.590 |
Why?
| | Herpes Zoster | 2 | 2015 | 334 | 0.590 |
Why?
| | Plasma Exchange | 1 | 2017 | 21 | 0.590 |
Why?
| | NF-kappa B | 7 | 2010 | 664 | 0.580 |
Why?
| | Virology | 1 | 2016 | 20 | 0.580 |
Why?
| | Antibodies, Monoclonal | 11 | 2009 | 1280 | 0.580 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 15 | 0.570 |
Why?
| | Enzyme Inhibitors | 3 | 2011 | 817 | 0.570 |
Why?
| | Herpesvirus 3, Human | 3 | 2015 | 386 | 0.570 |
Why?
| | Macrophage Activation | 1 | 2017 | 165 | 0.570 |
Why?
| | Myocarditis | 5 | 2009 | 94 | 0.570 |
Why?
| | Viruses | 6 | 2009 | 96 | 0.570 |
Why?
| | Prions | 3 | 2008 | 36 | 0.560 |
Why?
| | Caspases | 9 | 2013 | 267 | 0.540 |
Why?
| | Alzheimer Disease | 1 | 2021 | 512 | 0.540 |
Why?
| | Immunocompromised Host | 5 | 2009 | 198 | 0.530 |
Why?
| | History, 20th Century | 10 | 2016 | 281 | 0.520 |
Why?
| | Thrombocytopenia | 1 | 2017 | 184 | 0.520 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 31 | 0.520 |
Why?
| | Chikungunya Fever | 1 | 2016 | 62 | 0.520 |
Why?
| | Cerebrospinal Fluid | 7 | 2005 | 93 | 0.510 |
Why?
| | Propylene Glycols | 1 | 2015 | 26 | 0.510 |
Why?
| | Glial Fibrillary Acidic Protein | 5 | 2021 | 86 | 0.510 |
Why?
| | Gene Expression Regulation | 6 | 2010 | 2435 | 0.510 |
Why?
| | Valine | 1 | 2015 | 77 | 0.510 |
Why?
| | Medication Reconciliation | 1 | 2015 | 25 | 0.510 |
Why?
| | Sphingosine | 1 | 2015 | 33 | 0.510 |
Why?
| | Antibodies, Viral | 7 | 2019 | 538 | 0.500 |
Why?
| | Anti-Inflammatory Agents | 3 | 2017 | 466 | 0.500 |
Why?
| | Calpain | 4 | 2008 | 54 | 0.490 |
Why?
| | Encephalitis Viruses, Japanese | 1 | 2014 | 1 | 0.490 |
Why?
| | Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 3 | 0.490 |
Why?
| | Nervous System | 2 | 2007 | 64 | 0.490 |
Why?
| | Encephalitis, St. Louis | 1 | 2014 | 2 | 0.480 |
Why?
| | Encephalitis Virus, St. Louis | 1 | 2014 | 3 | 0.480 |
Why?
| | Drug Discovery | 1 | 2015 | 124 | 0.480 |
Why?
| | PrPSc Proteins | 2 | 2004 | 5 | 0.480 |
Why?
| | Capsid | 5 | 1997 | 77 | 0.480 |
Why?
| | Receptors, Death Domain | 1 | 2013 | 4 | 0.480 |
Why?
| | Interferon Type I | 2 | 2013 | 129 | 0.470 |
Why?
| | Viral Proteins | 8 | 2000 | 290 | 0.470 |
Why?
| | Peripheral Nervous System | 1 | 2013 | 19 | 0.470 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2007 | 56 | 0.460 |
Why?
| | Male | 48 | 2023 | 57478 | 0.460 |
Why?
| | Penicillins | 1 | 2013 | 52 | 0.460 |
Why?
| | Heart | 3 | 2011 | 630 | 0.460 |
Why?
| | Neuroglia | 3 | 2012 | 155 | 0.450 |
Why?
| | Epidemics | 1 | 2014 | 70 | 0.450 |
Why?
| | Viral Nonstructural Proteins | 2 | 2005 | 59 | 0.440 |
Why?
| | Carrier Proteins | 6 | 2013 | 725 | 0.440 |
Why?
| | Phagocytosis | 1 | 2014 | 360 | 0.430 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 454 | 0.430 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2012 | 22 | 0.430 |
Why?
| | Acute Disease | 6 | 2018 | 933 | 0.430 |
Why?
| | Enterovirus | 3 | 2023 | 72 | 0.420 |
Why?
| | DNA, Viral | 8 | 2003 | 351 | 0.420 |
Why?
| | STAT1 Transcription Factor | 3 | 2012 | 68 | 0.410 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 82 | 0.410 |
Why?
| | Animals, Newborn | 9 | 2021 | 804 | 0.400 |
Why?
| | United States | 13 | 2023 | 12495 | 0.400 |
Why?
| | Brain Diseases | 3 | 2020 | 141 | 0.400 |
Why?
| | bcl-2-Associated X Protein | 1 | 2011 | 46 | 0.390 |
Why?
| | Gene Expression Profiling | 3 | 2014 | 1590 | 0.380 |
Why?
| | Caspase 8 | 5 | 2013 | 47 | 0.380 |
Why?
| | Immunoglobulins, Intravenous | 3 | 2019 | 128 | 0.380 |
Why?
| | Female | 41 | 2021 | 61266 | 0.380 |
Why?
| | fas Receptor | 2 | 2009 | 98 | 0.380 |
Why?
| | Chemokines | 2 | 2022 | 228 | 0.380 |
Why?
| | History, 19th Century | 10 | 2010 | 61 | 0.380 |
Why?
| | Macrophages | 1 | 2017 | 1311 | 0.380 |
Why?
| | Genes, Viral | 9 | 1998 | 93 | 0.370 |
Why?
| | Virus Internalization | 2 | 2022 | 41 | 0.370 |
Why?
| | Cysteine Proteinase Inhibitors | 3 | 2001 | 50 | 0.370 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2007 | 21 | 0.360 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 111 | 0.360 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 225 | 0.360 |
Why?
| | Flavivirus Infections | 2 | 2019 | 9 | 0.360 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2003 | 1159 | 0.360 |
Why?
| | Immunomodulation | 1 | 2010 | 89 | 0.360 |
Why?
| | Up-Regulation | 5 | 2016 | 862 | 0.350 |
Why?
| | Cerebellum | 3 | 2012 | 203 | 0.350 |
Why?
| | Membrane Glycoproteins | 5 | 2004 | 443 | 0.350 |
Why?
| | Enzyme Activation | 3 | 2010 | 810 | 0.350 |
Why?
| | Cell Cycle | 2 | 2002 | 547 | 0.330 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 68 | 0.330 |
Why?
| | Cells, Cultured | 12 | 2013 | 4044 | 0.330 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2009 | 137 | 0.320 |
Why?
| | HeLa Cells | 7 | 2018 | 583 | 0.320 |
Why?
| | Discitis | 1 | 2008 | 3 | 0.320 |
Why?
| | Motor Neuron Disease | 1 | 2008 | 16 | 0.320 |
Why?
| | Bell Palsy | 1 | 2007 | 5 | 0.310 |
Why?
| | Bone Diseases, Infectious | 1 | 2008 | 8 | 0.310 |
Why?
| | Spinal Cord Diseases | 1 | 2008 | 39 | 0.310 |
Why?
| | Caspase 9 | 4 | 2013 | 50 | 0.310 |
Why?
| | Back Pain | 1 | 2008 | 44 | 0.310 |
Why?
| | Janus Kinases | 1 | 2007 | 14 | 0.310 |
Why?
| | Prednisolone | 1 | 2007 | 76 | 0.300 |
Why?
| | Rituximab | 3 | 2021 | 153 | 0.300 |
Why?
| | Cytomegalovirus | 2 | 2004 | 144 | 0.300 |
Why?
| | Wasting Disease, Chronic | 1 | 2007 | 19 | 0.300 |
Why?
| | Kuru | 2 | 2004 | 2 | 0.300 |
Why?
| | Apoptosis Regulatory Proteins | 7 | 2005 | 189 | 0.290 |
Why?
| | Adult | 26 | 2022 | 31324 | 0.290 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 59 | 0.280 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 251 | 0.280 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 461 | 0.280 |
Why?
| | Homosexuality, Male | 3 | 2022 | 165 | 0.270 |
Why?
| | Mitochondrial Proteins | 2 | 2005 | 224 | 0.270 |
Why?
| | Feces | 1 | 2008 | 392 | 0.270 |
Why?
| | Integrin alpha4 | 1 | 2005 | 6 | 0.270 |
Why?
| | Cytochromes c | 2 | 2005 | 63 | 0.270 |
Why?
| | Dogs | 4 | 2021 | 369 | 0.270 |
Why?
| | Viral Tropism | 2 | 2018 | 24 | 0.270 |
Why?
| | Mice, Knockout | 7 | 2012 | 2664 | 0.260 |
Why?
| | Child, Preschool | 9 | 2022 | 9448 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 10 | 2023 | 3169 | 0.260 |
Why?
| | Encephalomyelitis, Eastern Equine | 2 | 2019 | 6 | 0.260 |
Why?
| | Herpesvirus 4, Human | 2 | 2022 | 126 | 0.260 |
Why?
| | Opportunistic Infections | 1 | 2005 | 44 | 0.260 |
Why?
| | Child | 15 | 2022 | 19033 | 0.260 |
Why?
| | RNA, Viral | 5 | 2004 | 568 | 0.260 |
Why?
| | Health Surveys | 1 | 2007 | 453 | 0.260 |
Why?
| | Scrapie | 1 | 2004 | 2 | 0.250 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 226 | 0.250 |
Why?
| | Intracellular Signaling Peptides and Proteins | 4 | 2013 | 403 | 0.250 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 2003 | 219 | 0.250 |
Why?
| | History, 21st Century | 3 | 2016 | 170 | 0.250 |
Why?
| | Immunologic Factors | 2 | 2021 | 224 | 0.240 |
Why?
| | Oligodendroglia | 2 | 2003 | 152 | 0.240 |
Why?
| | Recombinant Proteins | 3 | 2023 | 1302 | 0.240 |
Why?
| | Cell Nucleus | 2 | 2004 | 577 | 0.240 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 112 | 0.240 |
Why?
| | Adjuvants, Immunologic | 1 | 2005 | 207 | 0.240 |
Why?
| | Mitochondria | 5 | 2016 | 785 | 0.240 |
Why?
| | Blotting, Western | 5 | 2010 | 1186 | 0.230 |
Why?
| | Hand, Foot and Mouth Disease | 1 | 2023 | 3 | 0.230 |
Why?
| | Medical Tourism | 1 | 2023 | 10 | 0.230 |
Why?
| | Encephalomyelitis, Acute Disseminated | 2 | 2020 | 12 | 0.230 |
Why?
| | Middle Aged | 23 | 2019 | 27512 | 0.230 |
Why?
| | Roseolovirus Infections | 1 | 2003 | 6 | 0.230 |
Why?
| | Age of Onset | 1 | 2005 | 465 | 0.230 |
Why?
| | Arthropod Vectors | 2 | 2016 | 7 | 0.230 |
Why?
| | Neutralization Tests | 4 | 2017 | 64 | 0.230 |
Why?
| | Reassortant Viruses | 3 | 2005 | 7 | 0.230 |
Why?
| | Herpesvirus 6, Human | 1 | 2003 | 13 | 0.230 |
Why?
| | Treatment Outcome | 8 | 2019 | 9319 | 0.230 |
Why?
| | Antigens, Viral | 4 | 2009 | 178 | 0.230 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2017 | 165 | 0.230 |
Why?
| | Immunization, Passive | 3 | 1993 | 80 | 0.230 |
Why?
| | Flavivirus | 2 | 2019 | 16 | 0.220 |
Why?
| | Glucocorticoids | 1 | 2007 | 545 | 0.220 |
Why?
| | Immunohistochemistry | 3 | 2017 | 1681 | 0.220 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 3 | 2009 | 10 | 0.220 |
Why?
| | Disease Progression | 7 | 2010 | 2476 | 0.220 |
Why?
| | Encephalomyelitis | 1 | 2022 | 9 | 0.220 |
Why?
| | Olfactory Mucosa | 1 | 2003 | 59 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 1 | 2011 | 990 | 0.220 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2003 | 80 | 0.220 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2017 | 665 | 0.220 |
Why?
| | Poliomyelitis | 1 | 2022 | 30 | 0.220 |
Why?
| | Organ Culture Techniques | 2 | 2014 | 149 | 0.220 |
Why?
| | HIV Infections | 2 | 2013 | 2454 | 0.220 |
Why?
| | Cytomegalovirus Infections | 1 | 2004 | 187 | 0.210 |
Why?
| | Virulence | 6 | 2005 | 239 | 0.210 |
Why?
| | Densitometry | 1 | 2022 | 30 | 0.210 |
Why?
| | Survival Analysis | 3 | 2018 | 1263 | 0.210 |
Why?
| | Poliovirus | 1 | 2022 | 78 | 0.210 |
Why?
| | Anti-Bacterial Agents | 5 | 2022 | 1514 | 0.210 |
Why?
| | Sequence Analysis, DNA | 4 | 2017 | 748 | 0.210 |
Why?
| | Pandemics | 2 | 2020 | 1338 | 0.210 |
Why?
| | Organ Transplantation | 1 | 2004 | 164 | 0.210 |
Why?
| | Exanthema | 1 | 2022 | 77 | 0.210 |
Why?
| | Ovarian Neoplasms | 1 | 2007 | 420 | 0.200 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 98 | 0.200 |
Why?
| | DNA Repair | 1 | 2003 | 197 | 0.200 |
Why?
| | Nervous System Malformations | 1 | 2022 | 33 | 0.200 |
Why?
| | Peptides | 1 | 2007 | 879 | 0.200 |
Why?
| | CDC2 Protein Kinase | 1 | 2001 | 27 | 0.200 |
Why?
| | Enterovirus A, Human | 1 | 2021 | 12 | 0.200 |
Why?
| | Stroke | 2 | 2020 | 1046 | 0.200 |
Why?
| | Interferons | 2 | 2014 | 151 | 0.200 |
Why?
| | Dipeptides | 1 | 2001 | 51 | 0.190 |
Why?
| | G2 Phase | 1 | 2000 | 33 | 0.190 |
Why?
| | Manuscripts, Medical as Topic | 1 | 2000 | 4 | 0.190 |
Why?
| | Herpes Zoster Ophthalmicus | 1 | 2020 | 5 | 0.190 |
Why?
| | DNA-Directed DNA Polymerase | 2 | 1998 | 45 | 0.190 |
Why?
| | Pigmentation Disorders | 1 | 2020 | 7 | 0.190 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 29 | 0.190 |
Why?
| | Encephalitis Virus, California | 2 | 2019 | 6 | 0.190 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 227 | 0.180 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2020 | 22 | 0.180 |
Why?
| | Ophthalmoplegia | 1 | 1999 | 9 | 0.180 |
Why?
| | Facial Paralysis | 1 | 1999 | 17 | 0.180 |
Why?
| | Thrombophilia | 1 | 2020 | 62 | 0.180 |
Why?
| | Inflammation | 3 | 2020 | 2545 | 0.180 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 147 | 0.180 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 1999 | 5 | 0.180 |
Why?
| | Immunoglobulin G | 3 | 2019 | 785 | 0.180 |
Why?
| | Bunyaviridae Infections | 1 | 2019 | 6 | 0.180 |
Why?
| | Craniofacial Abnormalities | 1 | 2020 | 59 | 0.180 |
Why?
| | Intracranial Hemorrhages | 1 | 2020 | 77 | 0.180 |
Why?
| | Pons | 1 | 1999 | 31 | 0.180 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 2855 | 0.180 |
Why?
| | Nerve Degeneration | 2 | 2011 | 43 | 0.180 |
Why?
| | Olfaction Disorders | 1 | 2020 | 47 | 0.180 |
Why?
| | Genes, pol | 2 | 1998 | 7 | 0.180 |
Why?
| | Mitosis | 1 | 2000 | 172 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 394 | 0.170 |
Why?
| | Time Factors | 9 | 2008 | 6367 | 0.170 |
Why?
| | Myelitis, Transverse | 1 | 2019 | 3 | 0.170 |
Why?
| | Gliosis | 1 | 2019 | 35 | 0.170 |
Why?
| | North America | 2 | 2019 | 265 | 0.170 |
Why?
| | MAP Kinase Kinase Kinase 1 | 3 | 2004 | 14 | 0.170 |
Why?
| | Writing | 1 | 2000 | 88 | 0.170 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 44 | 0.170 |
Why?
| | rho-Associated Kinases | 1 | 2019 | 84 | 0.170 |
Why?
| | Encephalitis Virus, Japanese | 1 | 2018 | 1 | 0.170 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 13 | 0.170 |
Why?
| | Mental Disorders | 1 | 2007 | 935 | 0.170 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 108 | 0.160 |
Why?
| | Abnormalities, Multiple | 1 | 2020 | 182 | 0.160 |
Why?
| | Choledochal Cyst | 1 | 1998 | 20 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 177 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 225 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 335 | 0.160 |
Why?
| | Organ Specificity | 2 | 2013 | 274 | 0.160 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1998 | 18 | 0.160 |
Why?
| | Interferon-alpha | 2 | 2011 | 191 | 0.160 |
Why?
| | Tissue Culture Techniques | 2 | 2021 | 66 | 0.160 |
Why?
| | Neurogenesis | 1 | 2019 | 105 | 0.160 |
Why?
| | Hybridomas | 2 | 1995 | 233 | 0.160 |
Why?
| | Skin | 1 | 2022 | 657 | 0.160 |
Why?
| | Glioblastoma | 1 | 2000 | 263 | 0.150 |
Why?
| | Neuromyelitis Optica | 1 | 2019 | 112 | 0.150 |
Why?
| | Brazil | 1 | 2017 | 107 | 0.150 |
Why?
| | Autoantibodies | 3 | 2021 | 1334 | 0.150 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 42 | 0.150 |
Why?
| | Dexamethasone | 2 | 2017 | 319 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 185 | 0.150 |
Why?
| | Movement Disorders | 1 | 2017 | 45 | 0.150 |
Why?
| | Memory Disorders | 2 | 2016 | 168 | 0.150 |
Why?
| | Microfilament Proteins | 1 | 2017 | 131 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 139 | 0.140 |
Why?
| | Transcription Factors | 1 | 2005 | 1567 | 0.140 |
Why?
| | Muscular Diseases | 1 | 2017 | 107 | 0.140 |
Why?
| | Brain Ischemia | 1 | 2020 | 309 | 0.140 |
Why?
| | Ticks | 1 | 2016 | 12 | 0.140 |
Why?
| | Encephalitis Viruses, Tick-Borne | 1 | 2016 | 7 | 0.140 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 215 | 0.140 |
Why?
| | Protein Binding | 3 | 2016 | 1969 | 0.140 |
Why?
| | Encephalopathy, Bovine Spongiform | 1 | 1995 | 2 | 0.140 |
Why?
| | Culicidae | 1 | 2016 | 29 | 0.140 |
Why?
| | Presynaptic Terminals | 1 | 2016 | 58 | 0.140 |
Why?
| | Colorado | 5 | 2022 | 4178 | 0.140 |
Why?
| | Microcephaly | 1 | 2016 | 54 | 0.140 |
Why?
| | Interferon-gamma | 1 | 2019 | 735 | 0.140 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 104 | 0.140 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1995 | 14 | 0.130 |
Why?
| | Biliary Atresia | 1 | 1998 | 224 | 0.130 |
Why?
| | DNA | 3 | 2017 | 1385 | 0.130 |
Why?
| | Agricultural Workers' Diseases | 1 | 1995 | 32 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2023 | 2262 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 548 | 0.130 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 31 | 0.130 |
Why?
| | Spleen | 4 | 2011 | 504 | 0.130 |
Why?
| | Myocardium | 3 | 2005 | 965 | 0.130 |
Why?
| | Brain Stem | 1 | 1995 | 104 | 0.130 |
Why?
| | Cell Count | 2 | 2005 | 315 | 0.130 |
Why?
| | Chikungunya virus | 1 | 2016 | 62 | 0.130 |
Why?
| | Cricetinae | 3 | 2012 | 261 | 0.130 |
Why?
| | Medulla Oblongata | 1 | 1994 | 33 | 0.130 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 817 | 0.130 |
Why?
| | Nerve Fibers | 1 | 1995 | 89 | 0.130 |
Why?
| | Fingolimod Hydrochloride | 1 | 2015 | 30 | 0.130 |
Why?
| | Cerebral Infarction | 1 | 1994 | 45 | 0.130 |
Why?
| | Virus Cultivation | 1 | 2014 | 25 | 0.130 |
Why?
| | Demyelinating Diseases | 1 | 1995 | 79 | 0.130 |
Why?
| | West Nile Virus Vaccines | 1 | 2014 | 1 | 0.120 |
Why?
| | Endopeptidases | 1 | 1994 | 71 | 0.120 |
Why?
| | Aged | 9 | 2019 | 19597 | 0.120 |
Why?
| | Receptors, Interleukin-17 | 1 | 2014 | 5 | 0.120 |
Why?
| | Facial Nerve | 2 | 2007 | 32 | 0.120 |
Why?
| | Neuronal Plasticity | 1 | 2016 | 219 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 2005 | 46 | 0.120 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 36 | 0.120 |
Why?
| | Epilepsy | 1 | 1998 | 290 | 0.120 |
Why?
| | Fibroblasts | 4 | 2007 | 835 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2014 | 25 | 0.120 |
Why?
| | Microarray Analysis | 1 | 2014 | 121 | 0.120 |
Why?
| | Treponema pallidum | 1 | 2013 | 6 | 0.120 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2005 | 82 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 296 | 0.120 |
Why?
| | Practice Guidelines as Topic | 3 | 2007 | 1433 | 0.120 |
Why?
| | Bacterial Toxins | 2 | 2012 | 105 | 0.120 |
Why?
| | Kidney | 2 | 2011 | 1351 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 896 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 1996 | 369 | 0.110 |
Why?
| | Tachycardia | 1 | 2013 | 48 | 0.110 |
Why?
| | Complement System Proteins | 1 | 2016 | 290 | 0.110 |
Why?
| | Propidium | 1 | 2013 | 4 | 0.110 |
Why?
| | Hydro-Lyases | 1 | 2013 | 4 | 0.110 |
Why?
| | Immunotherapy, Adoptive | 2 | 1993 | 191 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 3 | 0.110 |
Why?
| | Biomarkers | 2 | 2017 | 3568 | 0.110 |
Why?
| | Buffers | 1 | 2013 | 55 | 0.110 |
Why?
| | Cerebrospinal Fluid Proteins | 2 | 2005 | 9 | 0.110 |
Why?
| | Myocytes, Cardiac | 2 | 2009 | 470 | 0.110 |
Why?
| | Rats | 7 | 2012 | 5339 | 0.110 |
Why?
| | Leukocytosis | 2 | 2005 | 34 | 0.110 |
Why?
| | History, 18th Century | 2 | 2010 | 23 | 0.110 |
Why?
| | Phagosomes | 1 | 2012 | 43 | 0.110 |
Why?
| | B-Lymphocytes | 2 | 2009 | 767 | 0.110 |
Why?
| | Drug Design | 1 | 2013 | 158 | 0.110 |
Why?
| | Glutamic Acid | 1 | 2014 | 223 | 0.110 |
Why?
| | Etoposide | 2 | 2003 | 149 | 0.110 |
Why?
| | Genetic Techniques | 2 | 2011 | 60 | 0.100 |
Why?
| | Cytoplasm | 1 | 2013 | 269 | 0.100 |
Why?
| | STAT5 Transcription Factor | 1 | 2012 | 43 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 409 | 0.100 |
Why?
| | Fever | 1 | 2013 | 283 | 0.100 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2011 | 8 | 0.100 |
Why?
| | Nitrendipine | 1 | 1991 | 13 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2005 | 1937 | 0.100 |
Why?
| | Cyclosporins | 1 | 1991 | 60 | 0.100 |
Why?
| | Verapamil | 1 | 1991 | 32 | 0.100 |
Why?
| | Cerebral Cortex | 2 | 2005 | 415 | 0.100 |
Why?
| | T-Lymphocytes | 3 | 1998 | 1771 | 0.100 |
Why?
| | Histocytochemistry | 1 | 2011 | 82 | 0.100 |
Why?
| | Fatal Outcome | 3 | 2009 | 286 | 0.100 |
Why?
| | Infant | 5 | 2022 | 8254 | 0.100 |
Why?
| | GTP-Binding Proteins | 1 | 2011 | 147 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2003 | 764 | 0.090 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.090 |
Why?
| | Medical Illustration | 1 | 2010 | 9 | 0.090 |
Why?
| | History, 17th Century | 1 | 2010 | 18 | 0.090 |
Why?
| | Glutamate Plasma Membrane Transport Proteins | 1 | 2009 | 5 | 0.090 |
Why?
| | Hippocampus | 2 | 2005 | 735 | 0.090 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 31 | 0.090 |
Why?
| | Virus Physiological Phenomena | 1 | 2009 | 6 | 0.090 |
Why?
| | Disease Vectors | 1 | 2009 | 10 | 0.090 |
Why?
| | Greenhouse Effect | 1 | 2009 | 8 | 0.090 |
Why?
| | Microscopy | 1 | 2011 | 124 | 0.090 |
Why?
| | Animals, Wild | 1 | 2009 | 47 | 0.090 |
Why?
| | United Kingdom | 2 | 2003 | 234 | 0.090 |
Why?
| | Muscle, Skeletal | 2 | 2017 | 1515 | 0.090 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2009 | 2657 | 0.090 |
Why?
| | Smad1 Protein | 1 | 2009 | 20 | 0.090 |
Why?
| | Smad3 Protein | 1 | 2009 | 47 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 2 | 2012 | 186 | 0.080 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2009 | 12 | 0.080 |
Why?
| | Mutation | 4 | 2014 | 3435 | 0.080 |
Why?
| | Kinetics | 3 | 2005 | 1623 | 0.080 |
Why?
| | DNA Primers | 2 | 2003 | 532 | 0.080 |
Why?
| | Autophagy | 1 | 2012 | 312 | 0.080 |
Why?
| | Virus Activation | 3 | 2003 | 77 | 0.080 |
Why?
| | Receptors, Virus | 2 | 2005 | 78 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 1991 | 272 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 594 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2012 | 762 | 0.080 |
Why?
| | Epidural Space | 1 | 2008 | 6 | 0.080 |
Why?
| | Myokymia | 1 | 2007 | 3 | 0.080 |
Why?
| | Schizophrenia, Paranoid | 1 | 2007 | 10 | 0.080 |
Why?
| | STAT2 Transcription Factor | 1 | 2007 | 3 | 0.080 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2008 | 87 | 0.080 |
Why?
| | Prognosis | 3 | 2019 | 3425 | 0.080 |
Why?
| | Developing Countries | 1 | 2009 | 253 | 0.080 |
Why?
| | Adolescent | 6 | 2020 | 18364 | 0.080 |
Why?
| | Seizures | 2 | 2008 | 345 | 0.080 |
Why?
| | Intervertebral Disc | 1 | 2008 | 37 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2022 | 12931 | 0.080 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2007 | 50 | 0.080 |
Why?
| | Cell Movement | 2 | 2003 | 888 | 0.080 |
Why?
| | Morbidity | 1 | 2008 | 293 | 0.070 |
Why?
| | Disease Reservoirs | 1 | 2007 | 20 | 0.070 |
Why?
| | Herpesvirus Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
| | Vero Cells | 3 | 2012 | 69 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1622 | 0.070 |
Why?
| | Herpesviridae | 1 | 2007 | 20 | 0.070 |
Why?
| | Lung Transplantation | 1 | 2009 | 262 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 279 | 0.070 |
Why?
| | Global Health | 1 | 2009 | 309 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1714 | 0.070 |
Why?
| | Hemagglutinins, Viral | 1 | 1986 | 6 | 0.070 |
Why?
| | Transfusion Reaction | 1 | 2007 | 50 | 0.070 |
Why?
| | Hepatovirus | 1 | 1986 | 3 | 0.070 |
Why?
| | Risk | 1 | 2009 | 849 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 56 | 0.070 |
Why?
| | Meningitis, Aseptic | 2 | 2003 | 15 | 0.070 |
Why?
| | Mice, Inbred Strains | 4 | 1993 | 404 | 0.070 |
Why?
| | Virus Latency | 1 | 2007 | 80 | 0.070 |
Why?
| | S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 5 | 0.070 |
Why?
| | Serologic Tests | 1 | 2005 | 52 | 0.070 |
Why?
| | Cell Division | 2 | 2000 | 775 | 0.070 |
Why?
| | Risk Factors | 4 | 2009 | 8957 | 0.070 |
Why?
| | Glutathione | 1 | 2007 | 325 | 0.070 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2005 | 48 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 4887 | 0.070 |
Why?
| | Interferon beta-1a | 1 | 2005 | 12 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2005 | 181 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1157 | 0.070 |
Why?
| | Orthoreovirus, Avian | 1 | 2005 | 1 | 0.070 |
Why?
| | Analgesics | 1 | 2007 | 159 | 0.070 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 58 | 0.060 |
Why?
| | England | 2 | 2000 | 68 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2007 | 6541 | 0.060 |
Why?
| | Administration, Oral | 2 | 2004 | 753 | 0.060 |
Why?
| | Saimiri | 1 | 2004 | 6 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1856 | 0.060 |
Why?
| | Neurophysiology | 1 | 1984 | 16 | 0.060 |
Why?
| | Nuclear Lamina | 1 | 2004 | 10 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 964 | 0.060 |
Why?
| | Nuclear Pore | 1 | 2004 | 14 | 0.060 |
Why?
| | Digestive System | 1 | 2004 | 29 | 0.060 |
Why?
| | Nuclear Localization Signals | 1 | 2004 | 14 | 0.060 |
Why?
| | Serotyping | 1 | 2004 | 32 | 0.060 |
Why?
| | Pancreas Transplantation | 1 | 2004 | 64 | 0.060 |
Why?
| | Ultraviolet Rays | 2 | 1999 | 381 | 0.060 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2004 | 26 | 0.060 |
Why?
| | Random Allocation | 1 | 2005 | 344 | 0.060 |
Why?
| | Pregnancy | 1 | 2016 | 5672 | 0.060 |
Why?
| | Thalamus | 1 | 2005 | 80 | 0.060 |
Why?
| | Down-Regulation | 1 | 2007 | 623 | 0.060 |
Why?
| | Retinal Ganglion Cells | 1 | 1985 | 92 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 964 | 0.060 |
Why?
| | Inclusion Bodies, Viral | 1 | 2003 | 2 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2021 | 497 | 0.060 |
Why?
| | AIDS-Related Opportunistic Infections | 2 | 2009 | 113 | 0.060 |
Why?
| | Vinculin | 1 | 2003 | 11 | 0.060 |
Why?
| | Glycoproteins | 1 | 2005 | 317 | 0.060 |
Why?
| | Enterovirus B, Human | 1 | 2023 | 24 | 0.060 |
Why?
| | Reflex, Stretch | 1 | 1983 | 9 | 0.060 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2003 | 36 | 0.060 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2003 | 17 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4574 | 0.060 |
Why?
| | Hepatolenticular Degeneration | 1 | 1983 | 18 | 0.060 |
Why?
| | Herpesvirus 2, Human | 1 | 2003 | 28 | 0.060 |
Why?
| | Chorea | 1 | 1983 | 12 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 379 | 0.060 |
Why?
| | Isoxazoles | 1 | 2023 | 56 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 517 | 0.060 |
Why?
| | Liver | 1 | 2011 | 1804 | 0.060 |
Why?
| | District of Columbia | 1 | 2022 | 27 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1378 | 0.060 |
Why?
| | Luciferases | 1 | 2003 | 142 | 0.060 |
Why?
| | Muscular Dystrophies | 1 | 1983 | 36 | 0.050 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 41 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 1998 | 1202 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2023 | 142 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2003 | 268 | 0.050 |
Why?
| | Retina | 1 | 1985 | 278 | 0.050 |
Why?
| | Ribavirin | 1 | 2003 | 88 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 332 | 0.050 |
Why?
| | AIDS Dementia Complex | 1 | 2002 | 51 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 362 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 887 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1469 | 0.050 |
Why?
| | Models, Biological | 2 | 2003 | 1701 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2002 | 78 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 618 | 0.050 |
Why?
| | Body Fluids | 1 | 2001 | 62 | 0.050 |
Why?
| | Electromyography | 2 | 2017 | 326 | 0.050 |
Why?
| | Endoplasmic Reticulum | 1 | 2003 | 240 | 0.050 |
Why?
| | Patients | 1 | 2002 | 174 | 0.050 |
Why?
| | Ligands | 1 | 2003 | 565 | 0.050 |
Why?
| | Radiography | 1 | 2004 | 860 | 0.050 |
Why?
| | Creatine Kinase | 1 | 2001 | 75 | 0.050 |
Why?
| | Pain | 1 | 2007 | 736 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2004 | 2063 | 0.050 |
Why?
| | Fas-Associated Death Domain Protein | 1 | 2000 | 16 | 0.050 |
Why?
| | Phenotype | 1 | 2009 | 2937 | 0.050 |
Why?
| | Haplorhini | 1 | 2000 | 62 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2017 | 3155 | 0.050 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 33 | 0.050 |
Why?
| | Species Specificity | 2 | 1995 | 559 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2000 | 115 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 4 | 2009 | 2434 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2005 | 891 | 0.050 |
Why?
| | Bunyamwera virus | 1 | 2019 | 3 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2020 | 135 | 0.040 |
Why?
| | Knee Joint | 1 | 1983 | 353 | 0.040 |
Why?
| | Recurrence | 3 | 1995 | 971 | 0.040 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2020 | 48 | 0.040 |
Why?
| | Population Surveillance | 1 | 2003 | 413 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2837 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2020 | 95 | 0.040 |
Why?
| | Gerstmann-Straussler-Scheinker Disease | 1 | 1999 | 1 | 0.040 |
Why?
| | Creosote | 1 | 1999 | 2 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1048 | 0.040 |
Why?
| | Antidiarrheals | 1 | 1999 | 15 | 0.040 |
Why?
| | Muscle Weakness | 1 | 1999 | 82 | 0.040 |
Why?
| | Jejunum | 1 | 1999 | 30 | 0.040 |
Why?
| | Virus Attachment | 1 | 2018 | 11 | 0.040 |
Why?
| | Acrylates | 1 | 1999 | 47 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2004 | 539 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 288 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4522 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 556 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 48 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2990 | 0.040 |
Why?
| | Epitopes | 2 | 1991 | 439 | 0.040 |
Why?
| | Arboviruses | 1 | 2017 | 9 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2004 | 576 | 0.040 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 96 | 0.040 |
Why?
| | Vasculitis | 1 | 1998 | 74 | 0.040 |
Why?
| | Neural Pathways | 1 | 1999 | 277 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1082 | 0.040 |
Why?
| | Neural Conduction | 1 | 2017 | 81 | 0.040 |
Why?
| | Plant Extracts | 1 | 1999 | 164 | 0.040 |
Why?
| | Brain Mapping | 1 | 2000 | 530 | 0.040 |
Why?
| | Atrophy | 1 | 2017 | 164 | 0.040 |
Why?
| | Colon | 1 | 1999 | 237 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2004 | 844 | 0.040 |
Why?
| | Metagenomics | 1 | 2017 | 134 | 0.040 |
Why?
| | CA3 Region, Hippocampal | 1 | 2016 | 6 | 0.040 |
Why?
| | Spatial Memory | 1 | 2016 | 16 | 0.040 |
Why?
| | Complement Pathway, Classical | 1 | 2016 | 19 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 504 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2002 | 1161 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 354 | 0.030 |
Why?
| | Meat Products | 1 | 1995 | 25 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 66 | 0.030 |
Why?
| | Immunity, Cellular | 1 | 1998 | 268 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 935 | 0.030 |
Why?
| | Food Handling | 1 | 1995 | 48 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 1787 | 0.030 |
Why?
| | Phenylketonurias | 1 | 1995 | 13 | 0.030 |
Why?
| | Young Adult | 2 | 2022 | 10729 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 251 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1995 | 412 | 0.030 |
Why?
| | Ammonium Chloride | 1 | 1994 | 4 | 0.030 |
Why?
| | Chymotrypsin | 1 | 1994 | 20 | 0.030 |
Why?
| | Necrosis | 2 | 1998 | 230 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 717 | 0.030 |
Why?
| | Cognition Disorders | 2 | 2009 | 528 | 0.030 |
Why?
| | Complement Activation | 1 | 2016 | 344 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2148 | 0.030 |
Why?
| | Antibody Affinity | 1 | 1993 | 54 | 0.030 |
Why?
| | DNA Damage | 1 | 1995 | 356 | 0.030 |
Why?
| | Cell Survival | 2 | 2005 | 1045 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2013 | 17 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 1027 | 0.030 |
Why?
| | Thymidine Kinase | 2 | 1989 | 14 | 0.030 |
Why?
| | Syndrome | 2 | 2007 | 343 | 0.030 |
Why?
| | Cattle | 1 | 1995 | 974 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1995 | 275 | 0.030 |
Why?
| | Trigeminal Ganglion | 2 | 1989 | 21 | 0.030 |
Why?
| | Anti-HIV Agents | 1 | 1999 | 662 | 0.030 |
Why?
| | bcl-X Protein | 1 | 2012 | 41 | 0.030 |
Why?
| | Hemagglutination | 1 | 1991 | 7 | 0.030 |
Why?
| | Triterpenes | 1 | 2012 | 17 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1991 | 38 | 0.030 |
Why?
| | Immunoglobulin Isotypes | 1 | 1991 | 32 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2012 | 154 | 0.030 |
Why?
| | Proteolysis | 1 | 2012 | 146 | 0.030 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 84 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 5077 | 0.030 |
Why?
| | CD8 Antigens | 1 | 1991 | 70 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2013 | 173 | 0.030 |
Why?
| | Clone Cells | 1 | 1991 | 247 | 0.020 |
Why?
| | Diuresis | 1 | 1991 | 8 | 0.020 |
Why?
| | CD4 Antigens | 1 | 1991 | 126 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 394 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 1998 | 2857 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1991 | 508 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 341 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2012 | 186 | 0.020 |
Why?
| | Antibody Formation | 1 | 1991 | 275 | 0.020 |
Why?
| | Calcium Channels | 1 | 1991 | 149 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2009 | 9 | 0.020 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2009 | 13 | 0.020 |
Why?
| | CD11 Antigens | 1 | 2009 | 28 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 1989 | 28 | 0.020 |
Why?
| | Prospective Studies | 2 | 1998 | 6443 | 0.020 |
Why?
| | Esophagitis | 1 | 1989 | 66 | 0.020 |
Why?
| | Paresis | 1 | 2009 | 31 | 0.020 |
Why?
| | Incidence | 1 | 1995 | 2413 | 0.020 |
Why?
| | Precipitin Tests | 1 | 1988 | 94 | 0.020 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 1988 | 37 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2009 | 152 | 0.020 |
Why?
| | Optic Neuritis | 1 | 2009 | 37 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 1988 | 164 | 0.020 |
Why?
| | Dendrites | 1 | 2009 | 88 | 0.020 |
Why?
| | Cross Reactions | 1 | 1988 | 116 | 0.020 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2009 | 78 | 0.020 |
Why?
| | Muscles | 1 | 1989 | 332 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 38 | 0.020 |
Why?
| | Genetic Variation | 1 | 1993 | 912 | 0.020 |
Why?
| | Isaacs Syndrome | 1 | 2007 | 5 | 0.020 |
Why?
| | Skin Diseases | 1 | 2009 | 125 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 126 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 1991 | 1062 | 0.020 |
Why?
| | Peripheral Nerves | 1 | 2007 | 65 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 1991 | 681 | 0.020 |
Why?
| | Gene Expression | 1 | 2012 | 1482 | 0.020 |
Why?
| | Oxidants | 1 | 2007 | 119 | 0.020 |
Why?
| | Superoxides | 1 | 2007 | 195 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1986 | 33 | 0.020 |
Why?
| | Prednisone | 1 | 2007 | 235 | 0.020 |
Why?
| | Forelimb | 1 | 1986 | 29 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 808 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 1998 | 4684 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 1986 | 46 | 0.020 |
Why?
| | Synapses | 1 | 2009 | 344 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 1986 | 59 | 0.020 |
Why?
| | Hindlimb | 1 | 1986 | 137 | 0.020 |
Why?
| | Graft Rejection | 1 | 2009 | 547 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2005 | 38 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2005 | 96 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2016 | 5230 | 0.020 |
Why?
| | Politics | 1 | 1986 | 80 | 0.020 |
Why?
| | rho GTP-Binding Proteins | 1 | 2005 | 64 | 0.020 |
Why?
| | Integrins | 1 | 2005 | 82 | 0.020 |
Why?
| | Pathology | 1 | 1984 | 20 | 0.020 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.020 |
Why?
| | Muromegalovirus | 1 | 2004 | 13 | 0.020 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2004 | 20 | 0.020 |
Why?
| | Massachusetts | 1 | 1984 | 141 | 0.020 |
Why?
| | Blood Pressure | 1 | 1991 | 1656 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2005 | 435 | 0.010 |
Why?
| | Aphasia | 1 | 2003 | 23 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2003 | 28 | 0.010 |
Why?
| | Immunotherapy | 1 | 2007 | 493 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 26 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 564 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 167 | 0.010 |
Why?
| | Schools, Medical | 1 | 1984 | 138 | 0.010 |
Why?
| | Patella | 1 | 1983 | 25 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 90 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 2002 | 12 | 0.010 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 90 | 0.010 |
Why?
| | Hydrolysis | 1 | 2003 | 176 | 0.010 |
Why?
| | Intestines | 1 | 1986 | 330 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2003 | 100 | 0.010 |
Why?
| | Fluorescence | 1 | 2003 | 159 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 2003 | 172 | 0.010 |
Why?
| | Hypertrophy | 1 | 1983 | 121 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2002 | 116 | 0.010 |
Why?
| | Headache | 1 | 2003 | 128 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2002 | 52 | 0.010 |
Why?
| | DNA Fingerprinting | 1 | 2002 | 26 | 0.010 |
Why?
| | Electroencephalography | 1 | 2003 | 387 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2007 | 1167 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 980 | 0.010 |
Why?
| | Liver Diseases | 1 | 2003 | 283 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 541 | 0.010 |
Why?
| | Multienzyme Complexes | 1 | 2000 | 64 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2000 | 61 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 871 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 406 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2000 | 139 | 0.010 |
Why?
| | Drug Resistance, Microbial | 2 | 1989 | 67 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2004 | 695 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 59 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 359 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2004 | 979 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 516 | 0.010 |
Why?
| | HIV Seropositivity | 1 | 1998 | 111 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 610 | 0.010 |
Why?
| | Diet, Protein-Restricted | 1 | 1995 | 10 | 0.010 |
Why?
| | Phenylalanine | 1 | 1995 | 66 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1343 | 0.010 |
Why?
| | Immunoblotting | 1 | 1994 | 304 | 0.010 |
Why?
| | Lymphocyte Depletion | 1 | 1993 | 116 | 0.010 |
Why?
| | Lymphocytes | 1 | 1994 | 347 | 0.010 |
Why?
| | Amino Acids | 1 | 1995 | 462 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2002 | 1959 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1989 | 24 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1989 | 75 | 0.010 |
Why?
| | Chromosome Deletion | 1 | 1989 | 95 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1989 | 193 | 0.010 |
Why?
| | Genes | 1 | 1989 | 227 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2214 | 0.010 |
Why?
| | Eye | 1 | 1989 | 105 | 0.000 |
Why?
| | Codon | 1 | 1986 | 88 | 0.000 |
Why?
|
|
Tyler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|